Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Peringkat dalam Saham #18727
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Harga Saham
$2.35
Kapitalisasi Pasar
$4.22M
Perubahan (1 hari)
-5.69%
Perubahan (1 tahun)
838.98%
Negara
MY
Perdagangan BioNexus Gene Lab Corporation (BGLC)

Kategori

Rasio P/B untuk BioNexus Gene Lab Corporation (BGLC)
Rasio P/B per March 2026 TTM: 0.59
Menurut laporan keuangan dan harga saham terbaru dari BioNexus Gene Lab Corporation, rasio P/B saat ini (TTM) adalah 0.59. Pada akhir 2023, rasio P/B perusahaan adalah 0.95.
Riwayat rasio P/B untuk BioNexus Gene Lab Corporation dari 2016 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US